AbbVie gets EU nod for its giant cell arteritis treatment

AbbVie (NYSE:ABBV) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed Upadacitinib as a treatment for giant cell arteritis.

Issuing a positive opinion, EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended the